Taiwanese manufacturer to launch medical TPU innovations at Compamed 2025

Taiwan-based manufacturer and supplier of medical-grade TPU, ICP DAS-BMP (Biomedical Polymers), a Taiwan-based, is to launch two TPU innovations at this year’s Compamed. The trade fair is taking place from November 17 to 20 at Messe Düsseldorf, Germany.

ICP DAS-BMP will showcase two TPU innovations designed to address critical needs in medical device manufacturing: the Low-Migration Series and the Low-Friction Series.

The company says its low-migration Arothane ARP-B20 TPU (not to be confused with Huntsman’s Arathane) is ISO 10993 compliant and suitable for implantation up to 90 days. It reportedly minimizes additive migration during processing, helping catheters retain smooth surfaces throughout their shelf life, while offering 15 color options for flexible and customized design.

The Low-Friction Series, is engineered with an inherently smooth surface that eliminates the need for additional coatings or post-processing treatments. Composed entirely of TPU and free from PFAS or plasticizers, this series delivers reliable long-term stability without surface exudation or additive migration. Its low-friction properties make it particularly well-suited for applications requiring smooth insertion, such as nasogastric tubes with guidewires, while also ensuring safety and performance during storage and use.

In addition, ICP DAS-BMP will showcase a broad TPU portfolio covering varied medical needs. The ARP, ALP, and ALC series serve most body-contact devices, with ARP-B20 and ALC-B40 qualified for 90-day implantation. For radiopaque applications, the ARP-W and ARP-WG series use 40–60% tungsten to enhance visibility in guidewires and thin-walled devices. The Engineering Arothane EARP series is designed for orthodontics, Luer-Lock connectors, and other precision devices.

Photo by National Cancer Institute on Unsplash

ICP DAS-BMP